Literature DB >> 22291194

Fatal influenza B infections: time to reexamine influenza research priorities.

Jonathan A McCullers, Frederick G Hayden.   

Abstract

Mesh：

Year:  2012        PMID： 22291194     DOI： 10.1093/infdis/jir865

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  30 in total

Review 1.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

2.  Fitness costs for Influenza B viruses carrying neuraminidase inhibitor-resistant substitutions: underscoring the importance of E119A and H274Y.

Authors:  Andrew J Burnham; Tatiana Baranovich; Bindumadhav M Marathe; Jianling Armstrong; Robert G Webster; Elena A Govorkova
Journal:  Antimicrob Agents Chemother       Date:  2014-02-24       Impact factor: 5.191

3.  Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses.

Authors:  Louise A Carolan; Steve Rockman; Kathryn Borg; Teagan Guarnaccia; Patrick Reading; Jennifer Mosse; Anne Kelso; Ian Barr; Karen L Laurie
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

4.  The crystal structure of the PB2 cap-binding domain of influenza B virus reveals a novel cap recognition mechanism.

Authors:  Yong Liu; Yongfeng Yang; Jialin Fan; Ruina He; Ming Luo; Xiaofeng Zheng
Journal:  J Biol Chem       Date:  2015-02-17       Impact factor: 5.157

5.  Chimeric Hemagglutinin Constructs Induce Broad Protection against Influenza B Virus Challenge in the Mouse Model.

Authors:  Megan E Ermler; Ericka Kirkpatrick; Weina Sun; Rong Hai; Fatima Amanat; Veronika Chromikova; Peter Palese; Florian Krammer
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

6.  Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.

Authors:  Andrew J Burnham; Jianling Armstrong; Anice C Lowen; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

7.  Identification and characterization of viral defective RNA genomes in influenza B virus.

Authors:  Zizhang Sheng; Runxia Liu; Jieshi Yu; Zhiguang Ran; Simon J Newkirk; Wenfeng An; Feng Li; Dan Wang
Journal:  J Gen Virol       Date:  2018-02-12       Impact factor: 3.891

8.  A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.

Authors:  Bindumadhav M Marathe; Heba H Mostafa; Peter Vogel; Philippe Noriel Q Pascua; Jeremy C Jones; Charles J Russell; Richard J Webby; Elena A Govorkova
Journal:  Antiviral Res       Date:  2017-10-31       Impact factor: 5.970

9.  Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.

Authors:  Weina Sun; Davina S Kang; Allen Zheng; Sean T H Liu; Felix Broecker; Viviana Simon; Florian Krammer; Peter Palese
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

10.  Influenza-Induced Oxidative Stress Sensitizes Lung Cells to Bacterial-Toxin-Mediated Necroptosis.

Authors:  Norberto Gonzalez-Juarbe; Ashleigh N Riegler; Alexander S Jureka; Ryan P Gilley; Jeffrey D Brand; John E Trombley; Ninecia R Scott; Maryann P Platt; Peter H Dube; Chad M Petit; Kevin S Harrod; Carlos J Orihuela
Journal:  Cell Rep       Date:  2020-08-25       Impact factor: 9.995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.